For the quarter ending 2025-10-31, HQY had $4,798K increase in cash & cash equivalents over the period. $137,791K in free cash flow.
| Cash Flow | 2025-10-31 | 2025-07-31 |
|---|---|---|
| Net income | 51,692 | 113,769 |
| Depreciation and amortization | 38,780 | 77,195 |
| Stock-based compensation | 20,542 | 33,404 |
| Amortization of debt discount and issuance costs | 271 | 533 |
| Loss on extinguishment of debt | 0 | - |
| Deferred taxes | 12,023 | 30,711 |
| Accounts receivable, net | 79 | -6,842 |
| Prepaid expenses and other current and non-current assets | -12,206 | 20,650 |
| Operating lease right-of-use assets | -1,711 | -3,339 |
| Accrued compensation | 10,393 | -35,032 |
| Accounts payable, accrued liabilities, and other current liabilities | -7,484 | -3,785 |
| Operating lease liabilities, non-current | -2,012 | -3,951 |
| Other long-term liabilities | 532 | -1,771 |
| Net cash provided by operating activities | 138,575 | 200,604 |
| Purchases of software and capitalized software development costs | 10,304 | 26,464 |
| Purchases of property and equipment | 784 | 859 |
| Acquisitions of hsa portfolios | 293 | 0 |
| Net cash used in investing activities | -11,381 | -27,323 |
| Principal payments on long-term debt | 25,000 | 50,000 |
| Repurchases of common stock | 92,424 | 125,810 |
| Proceeds from long-term debt | 0 | 0 |
| Payment of debt issuance costs | 0 | - |
| Settlement of client-held funds obligation, net | -25 | -596 |
| Proceeds from exercise of common stock options | -4,997 | 10,446 |
| Net cash provided by (used in) financing activities | -122,396 | -164,768 |
| Increase (decrease) in cash and cash equivalents | 4,798 | 8,513 |
| Cash and cash equivalents at beginning of period | 295,948 | - |
| Cash and cash equivalents at end of period | 309,259 | - |
HEALTHEQUITY, INC. (HQY)
HEALTHEQUITY, INC. (HQY)